Close

UPDATE: Teva's (TEVA) '302 Capaxone Patent Invalidated by U.S. Patent Office

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SNV
5. INFY
6. TSLA
7. SPY
8. SLB
9. PPG
10. JWN


Go back to UPDATE: Teva's (TEVA) '302 Capaxone Patent Invalidated by U.S. Patent Office
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) Delayed: 52.48 --0 (-0%)
Previous Close $52.48    52 Week High $18.32 
Open $39.17    52 Week Low $7.86 
Day High $52.48    P/E N/A 
Day Low $52.48    EPS $-2.13 
Volume 147,551       

Mylan Inc. (NASDAQ: MYL) Delayed: 15.86 --0 (-0%)
Previous Close $15.86    52 Week High $55.51 
Open $10.56    52 Week Low $33.60 
Day High $15.86    P/E 10.43 
Day Low $15.86    EPS $1.52 
Volume 45,581       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 13.01 +0.23 (1.80%)
Previous Close $12.78    52 Week High $66.55 
Open $12.66    52 Week Low $37.82 
Day High $13.01    P/E N/A 
Day Low $12.51    EPS $0.00 
Volume 4,101,687